Van Dycke Jana, Cuvry Arno, Knickmann Jan, Ny Annelii, Rakers Sebastian, Taube Stefan, de Witte Peter, Neyts Johan, Rocha-Pereira Joana
KU Leuven-Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
University of Lübeck-Institute of Virology and Cell Biology, Lübeck, Germany.
Nat Protoc. 2021 Apr;16(4):1830-1849. doi: 10.1038/s41596-021-00499-0. Epub 2021 Apr 9.
We have recently established that human norovirus (HuNoV) replicates efficiently in zebrafish larvae after inoculation of a clinical sample into the yolk, providing a simple and robust in vivo system in which to study HuNoV. In this Protocol Extension, we present a detailed description of virus inoculation by microinjection, subsequent daily monitoring and harvesting of larvae, followed by viral RNA quantification. This protocol can be used to study viral replication of genogroup (G)I and GII HuNoVs in vivo within 3-4 d. Additionally, we describe how to evaluate the in vivo antiviral effect and toxicity of small molecules using HuNoV-infected zebrafish larvae, in multi-well plates and without the need for specific formulations. This constitutes a great advantage for drug discovery efforts, as no specific antivirals or vaccines currently exist to treat or prevent norovirus gastroenteritis.
我们最近证实,将临床样本接种到斑马鱼幼体的卵黄中后,人诺如病毒(HuNoV)能在其中高效复制,这为研究HuNoV提供了一个简单而强大的体内系统。在本方案扩展中,我们详细描述了通过显微注射接种病毒、随后每天对幼体进行监测和收集,以及病毒RNA定量的方法。该方案可用于在3-4天内研究基因组(G)I型和GII型HuNoV在体内的病毒复制情况。此外,我们还描述了如何在多孔板中使用HuNoV感染的斑马鱼幼体评估小分子的体内抗病毒效果和毒性,且无需特定配方。这对药物研发工作来说是一个巨大优势,因为目前尚无特异性抗病毒药物或疫苗来治疗或预防诺如病毒胃肠炎。